Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for early onset fetal growth restriction
NCT04557475Phase 3Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Jun 2022
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of aspirin in fetal growth restriction (FGR), sponsored by Johns Hopkins University. Planned start Jun 2022; status: withdrawn.
02
Drugs
aspirin
03
Conditions
fetal growth restriction (FGR)
Beyond the preview
Go deeper on NCT04557475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04557475.